Ablation is a minimally invasive procedure to treat abnormal electrical short circuits caused by a heart attack. These ...

From its cardiovascular divisions, Medtronic brought in $3.10 billion for an increase of 6.1%—driven in part by the launches ...

With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Diabetes shines, cardiac ablation stumbles, and new products spark hope--Medtronic's Q2 FY25 shakes up expectations.

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

The trial data provided clinical evidence indicating that LAAC with the WATCHMAN FLX device is safe and superior to oral anticoagulation (OAC) therapy for reducing the risk of long-term bleeding ...

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.

Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...

Atlanta-based Northside Hospital has treated its first patient using Medtronic's PulseSelect pulsed field ablation system for treating paroxysmal or persistent atrial fibrillation. The device, which ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for ...

A new study reveals a concerning trend: bowel cancer deaths among Millennials and Gen Xers in Europe are projected to rise.